- Novel Azole fused pyridinyl urea derivatives or pharmaceutically acceptable salts thereof, preparation method therof and pharmaceutical composition for use in preventing or treating Urotensin-Ⅱ receptor activity related diseases containing the same as an active ingredient
-
The present invention refers to novel azole-junction pyridyl urea derivatives or a pharmaceutically acceptable salt, including effect because of having immunosuppressive effect and manufacturing method thereof urotensin-II receptor activity associated for preventing or treating disease is directed to pharmaceutical composition. Azole the present invention according to a urea derivatives pyridyl-junction U-II receptor antagonist to may be based on congestive heart failure, heart ischemia, myocardial infarction, heart hyperplasia, cardiac fibrosis, coronary artery disease, arteriosclerosis, hypertension, asthma, renal failure, diabetes, vascular inflammatory, neurodegenerative diseases, stroke, pain, depression, such as psychotic and cancer-associated diseases, receptor activity U-II preventing or useful in the treatment of a, use can be made of,.
- -
-
-
- Substituted Phenylamino-Pyrimidines
-
The invention relates to substituted phenylaminopyrimidines, to a process for their preparation and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases in humans and animals, in particular cardiovascular disorders.
- -
-
-
- SUBSTITUTED PHENYLAMINO-PYRIMIDINES
-
The invention relates to substituted phenylamino-pyrimidines, to a method for their production and to their use for producing medicaments for the treatment and/or prophylaxis of diseases in humans and animals, in particular for the treatment of cardiovascular diseases.
- -
-
Page/Page column 52
(2010/02/14)
-